C
한국비티비
219750KOSDAQ의료용 기기 제조업41.5 / 100
Reference Date: 2026-06-10
Financial Score9.5 / 40
News Sentiment15.0 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Plunged 25.5% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Hanbitbi, established in 1999, is a medical device and biotechnology company that merged with Dongin Biotech in 2024, rebranding as Hanbitbi. Its Medical Device Division produces and sells anti-aging and beauty devices, including home beauty equipment, while the Bio Business Division supplies research reagents and equipment to biotech industries.
Number of Employees
100people
Average Salary
55.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 21.514.0Point
PBR
1.54Industry Average 1.382.5Point
Higher than industry avg (caution)
ROE
-14.97Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
54.19Industry Average 11.650.0Point
4.7x industry avg (risky)
Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲511.6% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼137.6% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -177.3% (improving, 3yr)
Detailed News Sentiment
1 totalPositive 0Neutral 0Negative 1Average Sentiment Score 60
- Negative한국비티비, 주식병합으로 4일부터 매매거래 정지
한국비티비의 주식병합으로 인한 매매거래 정지로 인해 투자자들의 불안감이 증가하고 있다.
Detailed Momentum
52-week position1.0Point
Near 52w low (0%, downtrend)
Current 571Won52-week high 1,40352-week low 571
1-month return0.0Point
1m -25.46% (strong drop)
Volume trend6.0Point
Volume surge
Detailed Disclosure
3 totalPositive 0Neutral 3Negative 0
- Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-06-01
- Neutral임시주주총회결과2026-05-19
- Neutral분기보고서 (2026.03)2026-05-15